aTyr Pharma (ATYR) Posts Wider-Than-Expected Loss as Investor Litigation Over Key Drug’s Efficacy Moves Forward — Hagens Berman
aTyr Pharma (ATYR) Posts Wider-Than-Expected Loss as Investor Litigation Over Key Drug's Efficacy Moves Forward — Hagens Berman ATYR Investors with Losses Encouraged to Contact Hagens Berman GlobeNewswire November 24, 2025 SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) — The financial and legal pressures on aTyr Pharma, Inc. (NASDAQ: ATYR) intensified earlier this month as […]